Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alimta and Gemzar in metastatic breast cancer
NCT00063570Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2003
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pemetrexed, gemcitabine in breast cancer, sponsored by Eli Lilly and Company. Started Jul 2003; status: completed.
02
Drugs
pemetrexedgemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00063570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063570.